Lifevantage (NASDAQ:LFVN) Stock Crosses Above 200-Day Moving Average – Time to Sell?

Lifevantage Corporation (NASDAQ:LFVN)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.73 and traded as high as $10.50. Lifevantage shares last traded at $9.49, with a volume of 710,001 shares.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Weiss Ratings upgraded shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Lake Street Capital cut shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price objective on the stock. in a research note on Thursday, May 7th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $5.00.

Lifevantage Stock Performance

The company’s fifty day moving average is $5.93 and its 200-day moving average is $5.73. The company has a market capitalization of $119.76 million, a PE ratio of 21.09 and a beta of 0.69.

Lifevantage (NASDAQ:LFVN) last released its earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The firm had revenue of $43.72 million during the quarter, compared to analysts’ expectations of $47.77 million. Lifevantage had a return on equity of 23.89% and a net margin of 2.94%. On average, sell-side analysts expect that Lifevantage Corporation will post 0.6 EPS for the current fiscal year.

Lifevantage Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.20 annualized dividend and a yield of 2.1%. This is a positive change from Lifevantage’s previous quarterly dividend of $0.05. Lifevantage’s payout ratio is currently 44.44%.

Institutional Investors Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC purchased a new stake in Lifevantage during the 1st quarter valued at approximately $97,000. Jones Financial Companies Lllp grew its holdings in Lifevantage by 14,484.0% during the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock valued at $425,000 after buying an additional 28,968 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Lifevantage by 24.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock valued at $649,000 after buying an additional 8,762 shares in the last quarter. Jane Street Group LLC grew its holdings in Lifevantage by 5.4% during the 1st quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock valued at $533,000 after buying an additional 1,877 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock valued at $3,210,000 after buying an additional 126,274 shares in the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.